Who owns BIOMARIN PHARMACEUTICAL?
- CUSIP Number: 09061gak7
Tip: Access positions for across all investors
Analyze quarterly positions in Biomarin Pharmaceutical with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Biomarin Pharmaceutical stock
Who bought or sold BIOMARIN PHARMACEUTICAL this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| MacKay Shields | 76M | $78M | 0% | Dec 2023 |
|
| Lazard Asset Management | 51M | $53M | 0% | Dec 2023 |
|
| Wellesley Investment Advisors | 41M | $42B | -14% | Dec 2023 |
|
| iA Global Asset Management | 15M | $15M | 0% | Dec 2023 |
|
| Victory Capital Management | 14M | $14M | -26% | Dec 2023 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 14M | $14M | -3% | Dec 2023 |
|
| Shenkman Capital Management | 12M | $12B | 4752% | Dec 2023 |
|
| Bank of America Corporation | 7.2M | $7.4M | -8% | Dec 2023 |
|
| Jpmorgan Chase & Co | 5.4M | $5.6M | 1299% | Dec 2023 |
|
| Wellington Management Company | 5.1M | $5.2M | 134% | Dec 2023 |
|
| Amundi | 5.0M | $5.1M | 0% | Dec 2023 |
|
| New York State Common Retirement Fund | 4.6M | $4.7M | -3% | Dec 2023 |
|
| Bnp Paribas Investment Partners | 4.4M | $4.5M | 0% | Dec 2023 |
|
| SSI Investment Management | 4.2M | $4.4M | 100% | Dec 2023 |
|
| La Banque Postale Asset Management SA | 3.1M | $3.2M | 210% | Dec 2023 |
|
| Pier 88 Investment Partners | 2.6M | $2.7M | 39% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 2.6M | $2.7M | 0% | Dec 2023 |
|
| Huntington Asset Advisors | 2.5M | $2.5M | 0% | Mar 2024 |
|
| Man Group | 2.2M | $2.2M | 30% | Dec 2023 |
|
| Kornitzer Capital Management | 2.0M | $2.1M | 100% | Dec 2023 |
|
| Palisade Capital Management | 1.9M | $2.0M | 0% | Dec 2023 |
|
| Edmond De Rothschild Holding | 1.2M | $1.2M | 0% | Dec 2023 |
|
| Liberty Mutual Group Asset Management | 1.0M | $1.1M | 0% | Dec 2023 |
|
| Banque Pictet & Cie Sa | 568k | $586k | -11% | Dec 2023 |
|
| Kohlberg Kravis Roberts & Co | 535k | $552k | 143% | Dec 2023 |
|
| Barclays | 347k | $358k | 100% | Dec 2023 |
|
| Bank of New York Mellon | 300k | $310k | 50% | Dec 2023 |
|
| Zurcher Kantonalbank | 200k | $197k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 126k | $130k | 12500% | Dec 2023 |
|
| D.A. Davidson & Co. | 110k | $113k | 0% | Dec 2023 |
|
| First Hawaiian Bank | 102k | $101k | 0% | Mar 2024 |
|
| Raab & Moskowitz Asset Management | 30k | $31k | 0% | Dec 2023 |
|
| Calamos Advisors | 16k | $17k | 0% | Dec 2023 |
|
| Aurum Wealth Management Group | 14k | $14k | 0% | Dec 2023 |
|
| Foresight Capital Management Advisors | 13k | $13k | 0% | Mar 2024 |
|
| Leisure Capital Management | 12k | $12k | 0% | Dec 2023 |
|
| Capital Investment Advisors | 11k | $11k | 0% | Mar 2024 |
|
| Raymond James Financial Services Advisors | 10k | $9.9k | 0% | Mar 2024 |
|
| Davenport & Co | 100.00 | $10k | -99% | Dec 2023 |
|
| Advisor Group Holdings | 33.00 | $34k | 0% | Dec 2023 |
|